Melius MicroBiomics Inc. (MMB)
The Gibson Lab created two genetically engineered microbial medicines (GEMM™), BioPersist™ & BioColonize™. Melius MicroBiomics Inc. has licensed this UBC IP to take these products to market. Dr. Deanna Gibson is the current CSO of MMB.
Learn more here
![](https://blogs.ubc.ca/gibsonlab/files/2024/04/Screenshot-2024-04-10-at-2.54.36 PM-1024x416.png)
![](https://blogs.ubc.ca/gibsonlab/files/2024/04/DSC4835-1024x683.jpg)